Award Underscores eVisit's Role as the Trusted Partner for Health System Digital Care Transformation WASHINGTON, Feb. 5, 2025 /PRNewswire/ -- eVisit,...
Wins validate unified platform strategy connecting provider scheduling optimization with clinical collaboration across care settings KNOXVILLE, Tenn., Feb. 5, 2025...
The Period Care Company Emerges from Stealth with Launch of Secure Period Tracking App NASHVILLE, Tenn., Feb. 5, 2025 /PRNewswire/...
SAN RAMON, Calif., Feb. 5, 2025 /PRNewswire/ -- Cozeva, a leading healthcare technology platform for risk, quality, and value-based care,...
Again earns top rankings for Strategy, Growth, and Consolidation, Revenue Cycle Optimization, and Outsourced Coding WASHINGTON, Feb. 5, 2025 /PRNewswire/...
FinThrive Insurance Discover™ leads the market with an overall score of 91.6 PLANO, Texas, Feb. 5, 2025 /PRNewswire/ -- FinThrive,...
AUSTIN, Texas, Feb. 5, 2025 /PRNewswire/ -- KLAS Research's 2025 Best in KLAS - Software and Services report has named...
Receives multiple Best in KLAS awards in Claims Management & Clearinghouse and Patient Access LEHI, Utah and LOUISVILLE, Ky., Feb. 5,...
FlexRx(TM) One Medication Adherence Packaging Wins Best of Show for Package Innovation Design and Recognition for Carbon ReductionLondon, Ontario--(Newsfile Corp....
Despite 85% of mothers experiencing frequent bladder leaks during postpartum, the survey found only 15% of mothers received resources and...
WILMINGTON, Del., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced a...
DALLAS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations,...
SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic...
BETHESDA, Md., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
BASKING RIDGE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”), a clinical-stage biotechnology company...
FLORHAM PARK, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing medicines...
NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology...
SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused...